On January 4, 2018 Cue Biopharma, Inc., (NASDAQ: CUE) an immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat cancer and autoimmune diseases, reported that it will be featured as a presenting company at the upcoming 10th Annual Biotech Showcase Conference on January 9, 2018, in San Francisco, CA (Press release, Cue Biopharma, JAN 4, 2018, View Source [SID1234522915]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Presentation details:
Date: Tuesday, January 9, 2018
Time: 11:15 am PT
Duration: 15 minutes
Location: Franciscan Room B at the Ballroom Level of the Hilton San Francisco Union Square
Daniel Passeri, M.Sc., J.D., President and Chief Executive Officer of Cue Biopharma, will provide an overview of the Company’s technology platform and overall development strategy and give updates on key programs, including anticipated development milestones.